-

08:30:23 AM

SIEN Stock News

SIEN - Sientra Inc

08/11/22 4:05 PM

Nasdaq : SIEN

high short

Sientra Reports Second Quarter Revenue Growth Driven By Increased Acceleration in Reconstruction Channel

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced its financial results for the second quarter that ended June 30,

RHEA-AI

neutral

07/28/22 8:30 AM

Nasdaq : SIEN

conferencesearningshigh short

Sientra to Report Second Quarter 2022 Financial Results on August 11, 2022

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the second quarter of

RHEA-AI

neutral

07/11/22 9:00 AM

Nasdaq : SIEN

high short

Sientra Wins Premier’s Horizon Award for 2022 for Exceptional Customer Service, Engagement, and Value Creation

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a leading medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, was recently honored with the 2022 Supplier Horizon Award. Sientra was

RHEA-AI

very positive

07/06/22 9:00 AM

Nasdaq : SIEN

fda approvalhigh short

FDA Approves Sientra’s Low Plus Profile Projection Breast Implant

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”) announced today that the U.S. Food and Drug Administration (FDA) approved the Low

RHEA-AI

very positive

05/23/22 9:00 AM

Nasdaq : SIEN

conferenceshigh short

Sientra To Present At The William Blair 42nd Annual Growth Stock Conference

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the William Blair 42 nd Annual Growth Stock Conference, which takes place June 6-9, 2022. As part of the conference, the company’s management

RHEA-AI

neutral

05/18/22 4:30 PM

Nasdaq : SIEN

conferenceshigh short

Sientra To Participate At The 19th Annual Craig-Hallum Institutional Investor Conference

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the Virtual 19 th Annual Craig-Hallum Institutional Investor Conference, which takes place June 1 st , 2022. Craig-Hallum hosted events are

RHEA-AI

neutral

05/12/22 4:05 PM

Nasdaq : SIEN

high short

Sientra Reports Seventh Consecutive Quarter of Record Growth for First Quarter 2022

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a

RHEA-AI

neutral

05/03/22 5:30 PM

Nasdaq : SIEN

conferencesearningshigh short

Sientra to Report First Quarter 2022 Financial Results on May 12, 2022

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that it will release financial results for the first quarter of 2022

RHEA-AI

neutral

03/24/22 4:15 PM

Nasdaq : SIEN

conferenceshigh short

Sientra to Participate in the 2022 Virtual Growth Conference Presented by Maxim Group LLC and hosted by M-Vest on March 28th – 30th from 9:00 a.m. - 5:00 p.m. EDT

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic surgery, today announced that Company CEO Ron Menezes has been invited to present at the

RHEA-AI

neutral

03/24/22 8:00 AM

Nasdaq : SIEN

high short

Sientra Receives Regulatory Approval to Market Breast Implants in Canada

Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), a medical aesthetics company focused on enhancing lives by advancing the art of plastic

RHEA-AI

very positive

SIEN Data

IndustrySurgical and Medical Instrument Manufacturing
Websitewww.sientra.com
CeoJeffrey Nugent
Security nameSientra Inc
Issue typecs
SectorManufacturing
Sic code3842
Employees255
Tags
- Health Technology
- Medical Specialties
- Manufacturing
- Surgical and Medical Instrument Manufacturing
Address420 S Fairview Ave Ste 200
StateCalifornia
CitySanta Barbara
Zip93117-3654
CountryUnited States
Phone18055623500

About Sientra Inc

Headquartered in Santa Barbara, California, Sientra is a medical aesthetics company uniquely focused on plastic surgeons. The Company offers a suite of products designed to make a difference in patients' lives by enhancing their body image, growing their self-esteem, and restoring their confidence. Sientra has developed a broad portfolio of products with technologically differentiated characteristics, supported by independent laboratory testing and strong clinical trial outcomes. The Company's Breast Products Segment includes its Sientra round and shaped breast implants, the first fifth generation breast implants approved by the FDA for sale in the United States, its ground-breaking Allox2® breast tissue expander with patented dual-port and integral drain technology, and BIOCORNEUM®, the #1 performing, preferred and recommended scar gel of plastic surgeons(*). The Company's miraDry Segment, comprised of its miraDry® system, is approved for sale in over 56 international markets and is the only non-surgical, FDA-cleared device indicated for the permanent reduction of underarm sweat and hair and may also reduce odor.